NFKB1 and colorectal carcinoma: ALDH1L2 facilitates a redox protein TXN degradation and activates NF-κB, thereby upregulating CAT and SOD2, and eliminating ROS to protect cells from ROS-mediated apoptosis, thereby inducing radioresistance in CRC cells [124].